Acquisition & growth (0→1)

Nexbody was born in 2024, entering into a GLP-1 market with an increasing CAC.

The project only had a $10k budget to validate our value proposition.

Trust was a barrier: compounding credentials and medication effectiveness needed proof.

The task

I was responsible of building a repeatable pipeline of paying users while proving unit economics.

‍

Key Results:
- Blended CAC ≤ $200 with 2-month payback period.
- Onboarding completion rate ≥ 65%, and time from signup to appointment ≤ 72 hours.
- A high-velocity experimentation system that allows to run one A/B test per week .

MVP validation:
- Created brand and run a campaign for initial leads.
- User tested a Figma prototype for qualitative feedback.
- Run a Typeform intake to validate initial CVR.
- Interviewed interested patients to validate key assumptions.

Funnel optimizations:

Created cohorts of 200 to A/B test landing pages, onboarding flows, and retargeting/resurrection emails.
Added a chat widget to facilitate customer discovery.
Identified initial funnel drop-offs(email & payment request).
Compared metrics, recorded sessions, and real user tests for qualitative feedback.

‍

What worked:

Launched Google and Meta Ads with a key differentiator (immediate appointment, no scheduling).
A/B tested email request at the first step of the onboarding, in exchange for a 50% discount.
Redesigned intake to pre-qualify patients in under 1 minute.
Run weekly iterations of headlines, CTA order, pricing frames, behavioral nudges, and trust builders.
Offered to “pay after appointment” for hesitant users.